Jubilant Pharmova Ltd.

₹897.1

Jubilant Pharmova Ltd.

₹897.1

₹897.1

2.4 (0.27%) - 30 Apr 2025 12:58 PM

About Company

Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses. With a solid network of radio-pharmacies in the US, Jubilant’s Radiopharma business is engaged in manufacturing and supply of Radiopharmaceutical products and services. Its other businesses such as Allergy Immunotherapy, Contract Manufacturing of Sterile Injectables and Non-sterile products and Generics (Solid Dosage Formulations) caters to major regulated markets (USA, EU and other geographies) through five manufacturing facilities. The CRDMO segment (through Jubilant Biosys) provides collaborative research and partnership for Drug Discovery through two world class research centers in India. The company is also involved in the manufacturing of Active Pharmaceutical Products (API) through a US FDA approved facility in Nanjangud, Karnataka.

Market Cap. ₹14,251 Cr.
52 Week - High/Low ₹1,310/617
P/E Ratio 374.35
P/B Ratio 6.00
Enterprise Value ₹14,505 Cr.
ROE % 1.32
RSI Value 46.79
EMA 50 925.11
EMA 200 933.32
Market Cap. ₹14,251 Cr.
52 Week - High/Low ₹1,310/617
P/E Ratio 22.54
P/B Ratio 2.62
Enterprise Value ₹17,300 Cr.
ROE % 1.34
RSI Value 46.79
EMA 50 925.11
EMA 200 933.32

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.